Saptak Chem and Business Limited (BOM:506906)
India · Delayed Price · Currency is INR 36.45
+0.01 (0.03%)
At close: Jul 23, 2026
Saptak Chem and Business Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 2.53 | 0.08 | 0.26 | 1.41 | 0.1 |
Cash & Short-Term Investments | 2.53 | 2.53 | 0.08 | 0.26 | 1.41 | 0.1 |
Cash Growth | 2987.81% | 2987.81% | -67.84% | -81.95% | 1387.37% | -51.32% |
Accounts Receivable | - | - | - | - | 0.68 | 0.68 |
Other Receivables | - | - | 0.61 | 0.54 | 0.73 | 0.55 |
Receivables | - | - | 0.61 | 0.54 | 1.41 | 1.23 |
Other Current Assets | - | 8.95 | 0.66 | 0.82 | 7.43 | 5.7 |
Total Current Assets | - | 11.48 | 1.35 | 1.62 | 10.26 | 7.02 |
Other Long-Term Assets | - | - | - | 0 | 5.38 | 8.89 |
Total Assets | - | 11.48 | 1.35 | 1.62 | 15.64 | 15.91 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 0 | - | - | 8.09 | 8.46 |
Accrued Expenses | - | 0.03 | 0.24 | 0.02 | - | - |
Short-Term Debt | - | 26.54 | 23.69 | 23.3 | - | - |
Current Portion of Long-Term Debt | - | - | - | - | 28.91 | 28.87 |
Total Current Liabilities | - | 26.57 | 23.92 | 23.32 | 37 | 37.33 |
Other Long-Term Liabilities | - | -0 | - | 0 | - | - |
Total Liabilities | - | 26.57 | 23.92 | 23.32 | 37 | 37.33 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 10.73 | 107.32 | 107.32 | 107.32 | 107.32 |
Retained Earnings | - | -36.32 | -129.89 | -129.03 | -128.68 | -128.74 |
Comprehensive Income & Other | - | 10.5 | -0 | -0 | - | - |
Shareholders' Equity | -15.09 | -15.09 | -22.57 | -21.71 | -21.36 | -21.42 |
Total Liabilities & Equity | - | 11.48 | 1.35 | 1.62 | 15.64 | 15.91 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 26.54 | 26.54 | 23.69 | 23.3 | 28.91 | 28.87 |
Net Cash (Debt) | -24.01 | -24.01 | -23.6 | -23.05 | -27.5 | -28.78 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -7.92 | -22.33 | -21.99 | -21.47 | -25.62 | -26.81 |
Filing Date Shares Outstanding | 3.03 | 1.08 | 1.07 | 1.07 | 1.07 | 1.07 |
Total Common Shares Outstanding | 3.03 | 1.08 | 1.07 | 1.07 | 1.07 | 1.07 |
Working Capital | - | -15.09 | -22.57 | -21.71 | -26.74 | -30.3 |
Book Value Per Share | -14.04 | -14.01 | -21.03 | -20.22 | -19.90 | -19.95 |
Tangible Book Value | -15.09 | -15.09 | -22.57 | -21.71 | -21.36 | -21.42 |
Tangible Book Value Per Share | -14.04 | -14.01 | -21.03 | -20.22 | -19.90 | -19.95 |